Large network BrainCore Therapy operates a broad network of over 125 practices across the U.S. and Canada, presenting a scalable market opportunity for partnerships, franchise models, or B2B tech integrations that support multi-site rollout and centralized training.

Drugless niche Specializing in neurofeedback and Brainwave Dysregulation, the company targets patients with ADHD, insomnia, anxiety, PTSD and other neurological conditions, offering a defensible value proposition for clinics seeking non-pharmacological treatment offerings and complementary care partnerships.

Strengthening tech Active tech stack including WordPress, modern marketing tools, and analytics suggests opportunities to upsell enterprise marketing solutions, patient engagement platforms, or CRM improvements to optimize lead capture, scheduling, and retention across the network.

Healthy growth Reported revenue range of 25 to 50 million positions BrainCore as a mid-market enterprise with appetite for scalability investments, licensing opportunities, and co-marketing arrangements with suppliers of neurofeedback hardware, software, or training services.

Strategic partners With a multi-practice footprint and focus on mental health and neurological wellness, there is potential for collaborations with schools, clinics, and healthcare providers to expand access, referral networks, and data-driven outcomes reporting to support reimbursement and patient acquisition.